Back

Progression of vascular changing and hypertensive retinopathy during bradykinin B1 receptor antagonist treatment in SHR rats

29 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Best Posters 7 - Best Posters in hypertension basic research Hypertension, other ESC Premium Access ESC Congress 2017

About the speaker

Photo
Mr Laszlo Deres

University of Pecs, Pecs (Hungary)

4 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Associate Professor M. Marketou (Heraklion, GR)
Abstract Slides
Presentation thumbnail
Associate Professor M. Marketou (Heraklion, GR)
Abstract Slides
Presentation thumbnail
Associate Professor M. Marketou (Heraklion, GR)
Abstract Slides

Access the full session

Session thumbnail
Best Posters 7 - Best Posters in hypertension basic research

The Event

Event poster

ESC Congress 2017

29 August 2017 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac diastolic dysfunction in angiotensin II-treated hypertensive rats is associated with endothelial upregulation of SGLT1/2 in the macro and microcirculation: Protective effect of empagliflozin
29 June 2021
thumbnail
Congress Presentation
Prognostic role of advanced retinopathy of vascular etiology in coronary artery disease in very long-term follow-up.
7 April 2022
thumbnail
Congress Session
Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation
18 May 2025
thumbnail
Congress Presentation
Bradycardic effect of endothelial-specific bradykinin type-II receptors overexpression in mice: impact on blood pressure.
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources